Description

• Blue and white capsules containing while to almost white powder.

• Tranexamic Acid, BP- 500mg

• Tranexamic Acid is an antifibrinolytic compound which is a potent competitive inhibitor of the activation of plasminogen to plasmin. At much higher concentrations it is a non- competitive inhibitor of plasmin. The inhibitory effect of Tranexamic Acid in plasminogen activation by urokinase has been reported to be 6-100 times and by streptokinase 6-40 times greater than that of aminocaproic acid. The antifibrinolytic activity of Tranexamic Acid is approximately ten times greater than that of aminocaproic acid.

Indication:

• Short-term use of hemorrhage or risk of hemorrahage in increased fibrinolysis or fibrinogenolysis. Local fibrinolysis as occurs in the following conditions: Prosatatectomy and bladder  surgeery; Menorrhagia; Espistaxis; Conization of the cervix; Traumatic hyphaema; Hereditary angioneurotic edema; Management of dental extraction in hemophiliacs.

Dosage and Administration

• As prescribed by a licensed Veterinarian.